Loading...
Apatinib for heavily treated patients with non-small cell lung cancer: Report of a case series and literature review
Although many strategies have been developed for non-small cell lung cancer (NSCLC), more secondary and further treatments are needed due to drug resistance or tumor recurrence. Apatinib is a novel oral antiangiogenic agent and in this study, we aim to investigate the clinical value of apatinib in h...
Na minha lista:
| Udgivet i: | Saudi J Biol Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087811/ https://ncbi.nlm.nih.gov/pubmed/30108437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2017.12.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|